MAPK signal specificity: the right place at the right time

Trends in Biochemical Sciences

Volumn 31, Issue 5, 2006, Pages 268-275

  Murphy, Leon O ^a   Blenis, John ^b  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; IMMEDIATE EARLY PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PHOSPHOTRANSFERASE; RAS PROTEIN; SCAFFOLD PROTEIN;

CELL SURFACE; DYNAMICS; ENZYME ACTIVATION; ENZYME SPECIFICITY; EXTRACELLULAR MATRIX; IMMEDIATE EARLY GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; REVIEW;

EID: 33646336602     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2006.03.009     Document Type: Review

References (81)

1. Roux P.P., and Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68 (2004) 320-344
2. Sharrocks A.D. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2 (2001) 827-837
3. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80 (1995) 179-185
4. Cowley S., et al. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77 (1994) 841-852
5. Mansour S.J., et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265 (1994) 966-970
6. Whalen A.M., et al. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol. Cell. Biol. 17 (1997) 1947-1958
7. Dustin M.L., and Chan A.C. Signaling takes shape in the immune system. Cell 103 (2000) 283-294
8. Sharp L.L., et al. The influence of the MAPK pathway on T cell lineage commitment. Immunity 7 (1997) 609-618
9. Aoki Y., et al. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat. Genet. 37 (2005) 1038-1040
10. Solit D.B., et al. BRAF mutation predicts sensitivity to MEK inhibition. Nature 439 (2005) 358-362
11. Dikic I., et al. PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation. Curr. Biol. 4 (1994) 702-708
12. Traverse S., et al. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr. Biol. 4 (1994) 694-701
13. Schlessinger J., and Bar-Sagi D. Activation of Ras and other signaling pathways by receptor tyrosine kinases. Cold Spring Harb. Symp. Quant. Biol. 59 (1994) 173-179
14. Murphy L.O., et al. A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Mol. Cell. Biol. 24 (2004) 144-153
15. Le Roy C., and Wrana J.L. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol. 6 (2005) 112-126
16. Wiley H.S. Trafficking of the ErbB receptors and its influence on signaling. Exp. Cell Res. 284 (2003) 78-88
17. Yarden Y. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur. J. Cancer 37 Suppl. 4 (2001) S3-S8
18. Peschard P., and Park M. Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases. Cancer Cell 3 (2003) 519-523
19. Vieira A.V., et al. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274 (1996) 2086-2089
20. Boute N., et al. Dynamics of the interaction between the insulin receptor and protein tyrosine-phosphatase 1B in living cells. EMBO Rep. 4 (2003) 313-319
21. Romsicki Y., et al. Protein tyrosine phosphatase-1B dephosphorylation of the insulin receptor occurs in a perinuclear endosome compartment in human embryonic kidney 293 cells. J. Biol. Chem. 279 (2004) 12868-12875
22. Haj F.G., et al. Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum. Science 295 (2002) 1708-1711
23. Wunderlich W., et al. A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold MP1 on a late endosomal/lysosomal compartment. J. Cell Biol. 152 (2001) 765-776
24. Teis D., et al. Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev. Cell 3 (2002) 803-814
25. Bivona T.G., and Philips M.R. Ras pathway signaling on endomembranes. Curr. Opin. Cell Biol. 15 (2003) 136-142
26. Chiu V.K., et al. Ras signalling on the endoplasmic reticulum and the Golgi. Nat. Cell Biol. 4 (2002) 343-350
27. Bivona T.G., et al. Phospholipase Cγ activates Ras on the Golgi apparatus by means of RasGRP1. Nature 424 (2003) 694-698
28. 2+/calmodulin. J. Cell Biol. 170 (2005) 429-441
29. Rocks O., et al. An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 307 (2005) 1746-1752
30. Meder D., and Simons K. Cell biology. Ras on the roundabout. Science 307 (2005) 1731-1733
31. Johnson L., et al. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11 (1997) 2468-2481
32. Koera K., et al. K-ras is essential for the development of the mouse embryo. Oncogene 15 (1997) 1151-1159
33. Esteban L.M., et al. Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development. Mol. Cell. Biol. 21 (2001) 1444-1452
34. Sasagawa S., et al. Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat. Cell Biol. 7 (2005) 365-373
35. York R.D., et al. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392 (1998) 622-626
36. Bos J.L. All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral. EMBO J. 17 (1998) 6776-6782
37. Tanoue T., and Nishida E. Molecular recognitions in the MAP kinase cascades. Cell. Signal. 15 (2003) 455-462
38. Jacobs D., et al. Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev. 13 (1999) 163-175
39. Murphy L.O., et al. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4 (2002) 556-564
40. Tanoue T., et al. A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat. Cell Biol. 2 (2000) 110-116
41. Lee T., et al. Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry. Mol. Cell 14 (2004) 43-55
42. Robinson F.L., et al. Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1. J. Biol. Chem. 277 (2002) 14844-14852
43. Richards S.A., et al. Characterization of regulatory events associated with membrane targeting of p90 ribosomal S6 kinase 1. Mol. Cell. Biol. 21 (2001) 7470-7480
44. Roux P.P., et al. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. Mol. Cell. Biol. 23 (2003) 4796-4804
45. Dimitri C.A., et al. Spatially separate docking sites on ERK2 regulate distinct signaling events in vivo. Curr. Biol. 15 (2005) 1319-1324
46. Vinciguerra M., et al. Differential phosphorylation of c-Jun and JunD in response to the epidermal growth factor is determined by the structure of MAPK targeting sequences. J. Biol. Chem. 279 (2004) 9634-9641
47. Fantz D.A., et al. Docking sites on substrate proteins direct extracellular signal-regulated kinase to phosphorylate specific residues. J. Biol. Chem. 276 (2001) 27256-27265
48. rsk/MAPKAP kinase-1. Curr. Biol. 9 (1999) 281-284
49. Smith J.A., et al. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J. Biol. Chem. 274 (1999) 2893-2898
50. Tonks N.K., and Neel B.G. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr. Opin. Cell Biol. 13 (2001) 182-195
51. Bott C.M., et al. The sevenmaker gain-of-function mutation in p42 MAP kinase leads to enhanced signalling and reduced sensitivity to dual specificity phosphatase action. FEBS Lett. 352 (1994) 201-205
52. Charles C.H., et al. The growth factor-inducible immediate-early gene 3CH134 encodes a protein-tyrosine-phosphatase. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 5292-5296
53. Lau L.F., and Nathans D. Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J. 4 (1985) 3145-3151
54. Woods D., et al. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17 (1997) 5598-5611
55. Sewing A., et al. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol. Cell. Biol. 17 (1997) 5588-5597
56. Lundberg A.S., et al. Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 12 (2000) 705-709
57. Cook S.J., et al. Regulation of mitogen-activated protein kinase phosphatase-1 expression by extracellular signal-related kinase-dependent and Ca2+-dependent signal pathways in Rat-1 cells. J. Biol. Chem. 272 (1997) 13309-13319
58. Chung J., et al. Coordinate regulation of pp90rsk and a distinct protein-serine/threonine kinase activity that phosphorylates recombinant pp90rsk in vitro. Mol. Cell. Biol. 11 (1991) 1868-1874
59. Volmat V., et al. The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases. J. Cell Sci. 114 (2001) 3433-3443
60. Brondello J.M., et al. Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts. Oncogene 10 (1995) 1895-1904
61. Camps M., et al. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science 280 (1998) 1262-1265
62. Furthauer M., et al. Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling. Nat. Cell Biol. 4 (2002) 170-174
63. Torii S., et al. Sef is a spatial regulator for Ras/MAP kinase signaling. Dev. Cell 7 (2004) 33-44
64. Hanafusa H., et al. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat. Cell Biol. 4 (2002) 850-858
65. Kim H.J., and Bar-Sagi D. Modulation of signalling by Sprouty: a developing story. Nat. Rev. Mol. Cell Biol. 5 (2004) 441-450
66. Saxena M., et al. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase. Nat. Cell Biol. 1 (1999) 305-311
67. Paul S., et al. NMDA-mediated activation of the tyrosine phosphatase STEP regulates the duration of ERK signaling. Nat. Neurosci. 6 (2003) 34-42
68. Greenberg M.E., et al. Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells. J. Biol. Chem. 260 (1985) 14101-14110
69. Greenberg M.E., and Ziff E.B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311 (1984) 433-438
70. Fambrough D., et al. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes. Cell 97 (1999) 727-741
71. Chen R.H., et al. Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene 12 (1996) 1493-1502
72. Okazaki K., and Sagata N. The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J. 14 (1995) 5048-5059
73. Schreiber M., et al. Structure and chromosomal assignment of the mouse Fra-1 gene, and its exclusion as a candidate gene for OC (osteosclerosis). Oncogene 15 (1997) 1171-1178
74. Ofir R., et al. Phosphorylation of the C terminus of Fos protein is required for transcriptional transrepression of the c-fos promoter. Nature 348 (1990) 80-82
75. Curran T., et al. Viral and cellular Fos proteins: a comparative analysis. Cell 36 (1984) 259-268
76. Brusselbach S., et al. Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos. Oncogene 10 (1995) 79-86
77. Brown J.R., et al. Fos family members induce cell cycle entry by activating cyclin D1. Mol. Cell. Biol. 18 (1998) 5609-5619
78. Mackeigan J.P., et al. Graded mitogen-activated protein kinase activity precedes switch-like c-Fos induction in mammalian cells. Mol. Cell. Biol. 25 (2005) 4676-4682
79. Whitehurst A., et al. Stimulus-coupled spatial restriction of extracellular signal-regulated kinase 1/2 activity contributes to the specificity of signal-response pathways. Mol. Cell. Biol. 24 (2004) 10145-10150
80. Ferrell Jr. J.E., and Machleder E.M. The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science 280 (1998) 895-898
81. Lenormand P., et al. Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins. J. Cell Biol. 142 (1998) 625-633